CD28 costimulation is critical for experimental allergic asthma in HLA-DQ8 transgenic mice

Clinical Immunology

Volumn 106, Issue 2, 2003, Pages 83-94

  Chapoval, Svetlana P ^a   David, Chella S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Allergy; Co stimulation; HLA; Inflammation; MHC; Transgenic knockout

Indexed keywords

CD28 ANTIGEN; CYTOKINE; HLA DQ ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RAGWEED ANTIGEN;

ACUTE PHASE RESPONSE; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE MODEL; EOSINOPHIL; EXTRINSIC ASTHMA; HYPERACTIVITY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IMMUNOTHERAPY; LOEFFLER PNEUMONIA; LYMPHOCYTOSIS; MOUSE; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROVOCATION TEST; SECONDARY IMMUNE RESPONSE; SENSITIZATION; SPECIES COMPARISON; T LYMPHOCYTE ACTIVATION; TARGET CELL; TH2 CELL; TRANSGENIC MOUSE;

EID: 0037302539     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00002-0     Document Type: Article

References (61)

1. Linsley P.S., Ledbetter J.A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:1993;191-212.
2. Greenfield E.A., Nguyen K.A., Kuchroo V.K. CD28/B7 costimulation a review . Crit. Rev. Immunol. 18:1998;389-418.
3. Brunet J.F., Denizot F., Luciani M.F., Roux-Dosseto M., Suzan M., Mattei M.G., Golstein P. A new member of the immunoglobulin superfamily - CTLA-4. Nature. 328:1987;267-270.
4. Linsley P.S., Brady W., Urnes M., Grosmaire L.S., Damle N.K., Ledbetter J.A. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:1991;561-569.
5. Walunas T.L., Lenschow D.J., Bakker C.Y., Linsley P.S., Freeman G.J., Green J.M., Thompson C.B., Bluestone J.A. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1:1994;405-413.
6. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:1995;459-465.
7. Padrid P.A., Mathur M., Li X., Herrmann K., Qin Y., Cattamanchi A., Weinstock J., Elliott D., Sperling A.I., Bluestone J.A. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 18:1998;453-462.
8. Gonzalo J.A., Tian J., Delaney T., Corcoran J., Rottman J.B., Lora J., Al-Garawi A., Kroczek R., Gutierrez-Ramos J.C., Coyle A.J. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nature Immunol. 2:2001;597-604.
9. Keane-Myers A., Gause W.C., Linsley P.S., Chen S.J., Wills-Karp M. B7-CD28/CTLA-4 constimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:1997;2042-2049.
10. Krinzman S.J., De Sanctis G.T., Cernadas M., Mark D., Wang Y., Listman J., Kobzik L., Donovan C., Nassr K., Katona I., Christiani D.C., Perkins D.L., Finn P.W. Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model. J. Clin. Invest. 98:1996;2693-2699.
11. Harris N., Campbell C., Le Gros G., Ronchese F. Blockade of CD28/B7 co-stimulation by mCTLA4-Hgammal inhibits antigen-induced lung eosinophilia but not Th2 cell development or recruitment in the lung. Eur. J. Immunol. 27:1997;155-161.
12. Van Oosterhout A.J., Hofstra C.L., Shields R., Chan B., Van Ark I., Jardieu P.M., Nijkamp F.P. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 17:1997;386-392.
13. Keane-Myers A.M., Gause W.C., Finkelman F.D., Xhou X.D., Wills-Karp M. Development of murine allergic asthma is dependent upon B7-2 costimulation. J. Immunol. 160:1998;1036-1043.
14. Tsuyuki S., Tsuyuki J., Einsle K., Kopf M., Coyle A.J. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J. Exp. Med. 185:1997;1671-1679.
15. Jaffar Z., Roberts K., Pandit A., Djukanovic R., Holgate S.T. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am. J. Respir. Cell Mol. Biol. 20:1999;153-162.
16. Lordan J.L., Davies D.E., Wilson S.J., Dent G., Corkhill A., Jaffar Z., Roberts K., Djukanovic R., Holgate S.T. The role of CD28-B7 costimulation in allergen-induced cytokine release by bronchial mucosa from patients with moderately severe asthma. J. Allergy Clin. Immunol. 108:2001;976-981.
17. Hofer M.F., Jirapongsananuruk O., Trumble A.E., Leung D.Y. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J. Allergy Clin. Immunol. 101:1998;96-102.
18. Mark D.A., Donovan C.E., De Sanctis G.T., He H.Z., Cernadas M., Kobzik L., Perkins D.L., Sharpe A., Finn P.W. B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 22:2000;265-271.
19. Mathur M., Herrmann K., Qin Y., Gulmen F., Li X., Krimins R., Weinstock J., Elliott D., Bluestone J.A., Padrid P. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice. Am. J. Respir. Cell Mol. Biol. 21:1999;498-509.
20. Nabozny G.H., Baisch J.M., Cheng S., Cosgrove D., Griffiths M.M., Luthra H.S., David C.S. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis. A novel model for human polyarthritis. J. Exp. Med. 183:1996;27-37.
21. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeham A., Kawai K., Ohashi P.S., Thompson C.B., Mak T.W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 261:1993;609-612.
22. Bachmaier K., Pummerer C., Shahinian A., Ionescu J., Neu N., Mak T.W., Penninger J.M. Induction of autoimmunity in the absence of CD28 costimulation. J. Immunol. 157:1996;1752-1757.
23. Chapoval S.P., Nabozny G.H., Marietta E.V., Raymond E.L., Krco C.J., Andrews A.G., David C.S. Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. J. Clin. Invest. 103:1999;1707-1717.
24. Chapoval S.P., Marietta E.V., Smart M.K., David C.S. Requirements for allergen-induced airway inflammation and hyperreactivity in CD4-deficient and CD4-sufficient HLA-DQ transgenic mice. J. Allergy Clin. Immunol. 108:2001;764-771.
25. Hamelmann E., Schwarze J., Takeda K., Oshiba A., Larsen G.L., Irvin C.G., Gelfand E.W. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:1997;766-775.
26. Chapoval S.P., Neeno T., Krco C.J., Marietta E.V., Harders J., David C.S. HLA-DQ6 and HLA-DQ8 transgenic mice respond to ragweed allergen and recognize distinct set of epitopes on short and giant ragweed group 5 antigens. J. Immunol. 161:1998;2032-2037.
27. Brown D.R., Green J.M., Moskowitz N.H., Davis M., Thompson C.B., Reiner S.L. Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 184:1996;803-810.
28. King C.L., Xianli J., June C.H., Abe R., Lee K.P. CD28-deficient mice generate an impaired Th2 response to Schistosoma mansoni infection. Eur. J. Immunol. 26:1996;2448-2455.
29. Gause W.C., Chen S.J., Greenwald R.J., Halvorson M.J., Lu P., Zhou X.D., Morris S.C., Lee K.P., June C.H., Finkelman F.D., Urban J.F., Abe R. CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 158:1997;4082-4087.
30. Mittrucker H.W., Kohler A., Mak T.W., Kaufmann S.H. Critical role of CD28 in protective immunity against Salmonella typhimurium. J. Immunol. 163:1999;6769-6776.
31. Kundig T.M., Shahinian A., Kawai K., Mittrucker H.W., Sebzda E., Bachmann M.F., Mak T.W., Ohashi P.S. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity. 5:1996;41-52.
32. Green J.M., Noel P.J., Sperling A.I., Walunas T.L., Gray G.S., Bluestone J.A., Thompson C.B. Absence of B7-dependent responses in CD28-deficient mice. Immunity. 1:1994;501-508.
33. Liu Y., Jones B., Aruffo A., Sullivan K.M., Linsley P.S., Janeway C.A. Jr. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J. Exp. Med. 175:1992;437-445.
34. Wu Y., Zhou Q., Zheng P., Liu Y. CD28-independent induction of T helper cells and immunoglobulin class switches requires costimulation by the heat-stable antigen. J. Exp. Med. 187:1998;1151-1156.
35. Li Y., Hellstrom K.E., Newby S.A., Chen L. Costimulation by CD48 and B7-1 induces immunity against poorly immunogenic tumors. J. Exp. Med. 183:1996;639-644.
36. Gonzalez-Cabrero J., Wise C.J., Latchman Y., Freeman G.J., Sharpe A.H., Reiser H. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc. Natl. Acad. Sci. USA. 96:1999;1019-1023.
37. Shinde S., Wu Y., Guo Y., Niu Q., Xu J., Grewal I.S., Flavell R., Liu Y. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J. Immunol. 157:1996;2764-2768.
38. Kishimoto K., Dong V.M., Issazadeh S., Fedoseyeva E.V., Waaga A.M., Yamada A., Sho M., Benichou G., Auchincloss H. Jr., Grusby M.J., Khoury S.J., Sayegh M.H. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J. Clin. Invest. 106:2000;63-72.
39. Akiba H., Oshima H., Takeda K., Atsuta M., Nakano H., Nakajima A., Nohara C., Yagita H., Okumura K. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:1999;7058-7066.
40. Rogers P.R., Croft M. CD28, Ox-40, LFA-1, and CD4 modulation of Th1/Th2 differentiation is directly dependent on the dose of antigen. J. Immunol. 164:2000;2955-2963.
41. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., Nguyen T., Burwell T., Schneider H., Gonzalo J.A., Gosselin M., Owen L.R., Rudd C.E., Gutierrez-Ramos J.C. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:2000;95-105.
42. Tesciuba A.G., Subudhi S., Rother R.P., Faas S.J., Frantz A.M., Elliot D., Weinstock J., Matis L.A., Bluestone J.A., Sperling A.I. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J. Immunol. 167:2001;1996-2003.
43. Cannons J.L., Lau P., Ghumman B., DeBenedette M.A., Yagita H., Okumura K., Watts T.H. 4-1Bb ligand induces cell division, sustains survival, and enhances effector function of cd4 and cd8 t cells with similar efficacy. J. Immunol. 167:2001;1313-1324.
44. Turka L.A., Ledbetter J.A., Lee K., June C.H., Thompson C.B. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J. Immunol. 144:1990;1646-1653.
45. Vallejo A.N., Brandes J.C., Weyand C.M., Goronzy J.J. Modulation of CD28 expression distinct regulatory pathways during activation and replicative senescence . J. Immunol. 162:1999;6572-6579.
46. Bugeon L., Dallman M.J. Costimulation of T cells. Am. J. Respir. Crit. Care Med. 162:2000;S164-S168.
47. Tamura H., Dong H., Zhu G., Sica G.L., Flies D.B., Tamada K., Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:2001;1809-1816.
48. Rulifson I.C., Sperling A.I., Fields P.E., Fitch F.W., Bluestone J.A. CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158:1997;658-665.
49. Oki S., Otsuki N., Kohsaka T., Azuma M. Stat6 activation and Th2 cell proliferation driven by CD28 signals. Eur. J. Immunol. 30:2000;1416-1424.
50. Broide D. Fast flowing eosinophils. Am. J. Respir. Cell Mol. Biol. 26:2002;637-640.
51. Foster P.S., Hogan S.P., Yang M., Mattes J., Young I.G., Matthaei K.I., Kumar R.K., Mahalingam S., Webb D.C. Interleukin-5 and eosinophils as therapeutic targets for asthma. Trends Mol. Med. 8:2002;162-167.
52. Mattes J., Yang M., Mahalingam S., Kuchr J., Webb D.C., Simson L., Hogan S.P., Koskinen A., McKenzie A.N., Dent L.A., Rothenberg M.E., Matthaei K.I., Young I.G., Foster P.S. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airway hyperreactivity in experimental asthma. J. Exp. Med. 195:2002;1433-1444.
53. Kung T.T., Stelts D., Zurcher J.A., Jones H., Umland S.P., Kreutner W., Egan R.W., Chapman R.W. Mast cells modulate allergic pulmonary eosinophilia in mice. Am. J. Respir. Cell Mol. Biol. 12:1995;404-409.
54. Joos K., Gjata B., Danos O., von Boehmer H., Sarukhan A. Regulatory function of in vivo anergized CD4+ T cells. Proc. Natl. Acad. Sci. USA. 98:2001;8738-8743.
55. Akbari O., DeKruyff R.N., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2:2001;725-731.
56. Trinchieri G., Scott P. Interleukin-12 basic principles and clinical applications . Curr. Top. Microbiol. Immunol. 238:1999;57-78.
57. Walter M.J., Kajiwara N., Karanja P., Castro M., Holtzman M.J. Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med. 193:2001;339-351.
58. Kumar M., Behera A.K., Hu J., Lockey R.F., Mohapatra S.S. IFN-gamma and IL-12 plasmid DNAs as vaccine adjuvant in a murine model of grass allergy. J. Allergy Clin. Immunol. 108:2001;402-408.
59. Klinnert M.D., Nelson H.S., Price M.R., Adinoff A.D., Leung D.Y., Mrazek D.A. Onset and persistence of childhood asthma predictors from infancy . Pediatrics. 108:2001;E69.
60. Akkoc T., Tolunay S., Barlau I., Basaran M. Airway remodeling and serum total immunoglobulin E (IgE) levels in a murine model of asthma. J. Asthma. 38:2001;585-591.
61. Warren J.S., Barton P.A., Jones M.L. Contrasting roles for tumor necrosis factor in the pathogeneses of IgA and IgG immune complex lung injury. Am. J. Pathol. 138:1991;581-590.